Endothelial cell adhesion to the fibronectin CS5 domain in artificial extracellular matrix proteins

Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA 91125, USA.
Biomaterials (Impact Factor: 8.56). 11/2003; 24(23):4245-52. DOI: 10.1016/S0142-9612(03)00294-1
Source: PubMed


This study examines the spreading and adhesion of human umbilical vein endothelial cells (HUVEC) on artificial extracellular matrix (aECM) proteins containing sequences derived from elastin and fibronectin. Three aECM variants were studied: aECM 1 contains lysine residues periodically spaced within the protein sequence and three repeats of the CS5 domain of fibronectin, aECM 2 contains periodically spaced lysines and three repeats of a scrambled CS5 sequence, and aECM 3 contains lysines at the protein termini and five CS5 repeats. Comparative cell binding and peptide inhibition assays confirm that the tetrapeptide sequence REDV is responsible for HUVEC adhesion to aECM proteins that contain the CS5 domain. Furthermore, more than 60% of adherent HUVEC were retained on aECM 1 after exposure to physiologically relevant shear stresses (</=100dynes/cm(2)). Finally, the levels of thrombogenic markers (tissue plasminogen activator and plasminogen activator inhibitor-1) secreted by HUVEC monolayers on aECM 1 were found to be similar to those secreted by HUVEC monolayers cultured on fibronectin. These characteristics, along with the physical strength and elasticity of crosslinked films prepared from these materials, make aECM proteins promising candidates for application in small-diameter vascular grafts.

Download full-text


Available from: Sarah Heilshorn
  • Source
    • "In the presented work we proposed a method to modify PU surface with peptides containing REDV sequence, which has been proved to promote ECs adhesion and proliferation [9] [10] [11]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: One of the contemporary challenges for cardiovascular tissue engineers is to design hemocompatible biomaterials that promote neo-tissue formation. Despite many years of intensive research materials used to fabricate synthetic implants still cause clot formation in the bloodstream, which can have fatal consequences for the patient. Currently, the most promising strategy to fabricate non-thrombogenic materials is covering the implant surface with a layer of endothelial cells. Endothelial cells can be applied onto the synthetic implant before the procedure (in vitro endothelialization) or can be recruited from the bloodstream and the surrounding areas (in situ endothelialization). In the presented work, a method to modify polyurethane surface is proposed. The surface-modified materials are designed to selectively promote endothelial cell adhesion and proliferation. The modification is based on three-step process: surface activation, introduction of spacer and coupling of peptide to the spacer molecule. Colorimetric assays confirmed the successful incorporation of the proper functional groups after each modification step. As a modifying peptide we decided to use peptides containing REDV sequence, which has been proved to promote ECs adhesion and proliferation. In order to confirm the successful incorporation of peptides and visualize their surface distribution a set of materials with fluorescence stained peptides was prepared and analyzed with fluorescence microscopy. The number of HUVEC adhered to REDV-modified materials was significantly higher compared to the number of cells adhered to the non-modified polyurethane. © 2013 The Authors. Published by Elsevier Ltd. Selection and peer-review under responsibility of the Centre for Rapid and Sustainable Product Development, Polytechnic Institute of Leiria, Centro Empresarial da Marinha Grande.
    Full-text · Article · Jun 2013 · Procedia Engineering
  • Source
    • "In humans, about 20 different neurological disorders, such as Huntington's disease (Ashley and Warren 1995) or myoclonus epilepsy (Lalioti et al. 1997), have been associated with the expansion of trinucleotide repeats. Additionally, in biomimetic engineering, artificial proteins containing repeats of specific amino acids, such as an elastin-like polypeptide (ELP), have excellent properties in pharmaceutical (Kostal et al. 2004), or biomedical applications (DiZio and Tirrell 2003; Heilshorn et al. 2003). Since these tandem repeats involve abnormal physiological changes at transcription and translation processes (Wanker 2000) and sometimes may alter existing "
    [Show abstract] [Hide abstract]
    ABSTRACT: A new cloning method for generating multiple repeats of amino acids is described which can be used as biomaterials, protein polymers and biomedical applications. Although several traditional methods for cloning multiple repeats are still exploited, these are laborious and complicated because they must go through several consecutive cloning steps. To solve these problems, synthetic gene libraries encoding repetitive patterns were constructed by using non-template PCR. As a result, a 'length library' with fourteen different ELP repeating genes was constructed and expressed in a cell-free protein synthesis system. These results showed our novel cloning method is efficient, and has the potential capacity for synthesizing repetitive genes by PCR to be cloned in any commercial expression vectors.
    Full-text · Article · May 2011 · Biotechnology Letters
  • Source
    • "Extracellular matrixmimetic polypeptides, engineered with biological cues, represent another type of functional biomaterial, with intended applications in tissue engineering and/or controlled release. The widely exploited, fibronectin-derived cell adhesive arginyl-glycyl-aspartate (RGD) peptide domain has been incorporated into a variety of protein-based polymers – based on silk [47] [48], elastin [31] [35] [37] [49] and resilin [42] – to regulate the cell-adhesive function of the materials. Elaboration of multiple biological functions is straightforward with biosynthetic approaches, and materials that contain additional domains, such as proteolytic degradation sites and heparin-binding domains have also been reported [39] [42] [49]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: In this review, we describe our work on the design, characterization, and modification of a series of alanine-rich helical polypeptides with novel functions. Glycosylation of the polypeptides has permitted investigation of polymer architecture effects on multivalent interactions. One of the members of this polypeptide family exhibits polymorphological behavior that is easily manipulated via simple changes in solution pH and temperature. Polypeptide-based fibrils formed at acidic pH and high temperature were shown to direct the one-dimensional organization of gold nanoparticles via electrostatic interactions. As a precursor to fibrils, aggregates likely comprising alanine-rich cores form at low temperatures and acidic pH and reversibly dissociate into monomers upon deprotonation. PEGylation of these polypeptides does not alter the self-association or conformational behavior of the polypeptide, suggesting potential applications in the development of assembled delivery vehicles, as modification of the polypeptides should be a useful strategy for controlling assembly.
    Full-text · Article · Dec 2010 · Advanced drug delivery reviews
Show more